Softwr

HR · head to head

Unmind vs Woebot Health

Unmind logo

Unmind

HR

UK built workplace mental health platform combining therapy, coaching, manager training and a 24/7 helpline in one contract

From
On request
Rated
-
Full reviewWebsite
Woebot Health logo

Woebot Health

Healthcare

Conversational CBT chatbot that withdrew from consumer distribution and now sells only to payers and providers

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Unmind psychiatry and medication management are not core, so populations needing prescribing care are routed into the health system and the employer sees no continuity of care for the most acute cases.; Woebot Health the company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • They diverge on capability: Unmind covers Therapy and coaching, Woebot Health covers Scripted CBT dialogue.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Unmind and Woebot Health actually diverge.

Attributes where Unmind and Woebot Health differ
AttributeUnmindWoebot Health
PlatformsWeb, iOS, AndroidiOS, Android, Web
CategoryHRHealthcare

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Unmind

  • Therapy and coaching
  • Nova AI support
  • Content and courses
  • Accredited manager training
  • Anonymised insights
  • 24/7 global helpline
  • Critical incident response
  • Work-life practical support

Only in Woebot Health

  • Scripted CBT dialogue
  • Mood tracking
  • Crisis routing
  • Between-session support
  • Payer deployment
  • Provider copilot positioning
  • Research licensing
  • Population reporting

What people use each for

The jobs each tool is most often brought in to do.

Unmind

  • A UK or EU headquartered employer consolidating a wellbeing app, a therapy provider and a legacy EAP into one contract and one insights viewnot Woebot Health
  • A multinational needing a helpline that answers in local hours across European and Asian sites rather than a US-centric servicenot Woebot Health
  • An HR team that needs accredited manager training framed for UK and EU employment law rather than American normsnot Woebot Health
  • An organisation that has had a serious workplace incident and wants critical incident response inside the same contract as ongoing carenot Woebot Health

Woebot Health

  • A health plan wanting a low intensity behavioural health option for members on a waiting list for therapynot Unmind
  • A provider organisation offering structured between-session CBT practice to patients already in treatmentnot Unmind
  • A research group running a trial that needs a clinically scripted rather than generative conversational agent for safety reasonsnot Unmind
  • A payer targeting a specific population such as postpartum members where scripted CBT content already existsnot Unmind

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Unmind

  • Psychiatry and medication management are not core, so populations needing prescribing care are routed into the health system and the employer sees no continuity of care for the most acute cases.
  • Pricing is per employee per year across the whole eligible population, so an employer with low engagement pays for a large denominator regardless of how many people use anything.
  • Bundling therapy, helpline, content and training into one price makes benchmarking against point solutions genuinely difficult, and consultants often cannot produce a like-for-like comparison.
  • United States provider depth and health plan integration are weaker than European coverage, so a US-heavy employer will find the network and the benefits integration less mature.
  • The anonymised insights layer requires minimum group sizes before reporting, so smaller teams and country sites, precisely where an HR team suspects a problem, return no data.

Woebot Health

  • The company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • It is not an FDA cleared treatment for any indication, so it cannot be positioned to members as therapy and cannot substitute for a covered behavioural health benefit.
  • The scripted, non-generative design that makes it safe also makes it feel rigid next to current conversational AI, and engagement drops off quickly once users hit the edges of the script.
  • Published evidence is short-horizon symptom change in selected populations, mostly young adults, with little evidence of durable benefit or effect at whole-population scale.
  • With consumer distribution gone, the remaining business depends on a small number of payer and provider contracts, so a buyer should assume real vendor continuity risk over a multi-year term.

Pricing, plan by plan

Unmind

On request
  • Unmind workplace mental health platform$undefined/year
    • Per employee per year, invoiced to the employer
    • Modules including helpline, critical incident cover and manager training bundled or added
    • Minimum eligible population applies, oriented to large mid-market and enterprise

Woebot Health

On request
  • Woebot for payers and providers$undefined/year
    • Contracted per member per month or as a population licence
    • Sold to health plans and provider organisations, not to employers or individuals
    • No consumer purchase route since the app closed in June 2025

Which should you pick?

Choose Unmind if

  • You need therapy and coaching.
  • You work on Web, iOS, Android.
  • You also want nova ai support.
Unmind review

Choose Woebot Health if

  • You need scripted cbt dialogue.
  • You work on iOS, Android, Web.
  • You also want mood tracking.
Woebot Health review

Questions people ask

Is Unmind or Woebot Health better?
Neither clearly leads. Unmind starts at On request and Woebot Health at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Unmind or Woebot Health?
Unmind starts at On request and Woebot Health at On request.
Does Unmind or Woebot Health run on more platforms?
Unmind runs on Web, iOS, Android. Woebot Health runs on iOS, Android, Web.
What is Unmind best used for?
Unmind is most often used for a uk or eu headquartered employer consolidating a wellbeing app, a therapy provider and a legacy eap into one contract and one insights view, a multinational needing a helpline that answers in local hours across european and asian sites rather than a us-centric service, an hr team that needs accredited manager training framed for uk and eu employment law rather than american norms, an organisation that has had a serious workplace incident and wants critical incident response inside the same contract as ongoing care. Of those, a uk or eu headquartered employer consolidating a wellbeing app, a therapy provider and a legacy eap into one contract and one insights view and a multinational needing a helpline that answers in local hours across european and asian sites rather than a us-centric service are not what Woebot Health is typically brought in for.
What can Unmind do that Woebot Health cannot?
Unmind covers Therapy and coaching, Nova AI support, Content and courses, Accredited manager training. Woebot Health covers Scripted CBT dialogue, Mood tracking, Crisis routing, Between-session support.

Answered from the vendors’ own pages

Unmind: Does Unmind replace our EAP?

It is designed to, including the 24/7 helpline and critical incident response. Confirm the specific helpline coverage hours and languages for each country you operate in.

Woebot Health: Is Woebot still available?

Not to consumers. The consumer app closed in June 2025. The company continues to offer the product to payers, providers and researchers.

Unmind: How is it priced?

Per employee per year across the eligible population, invoiced to the employer. Rates are not published.

Woebot Health: Is it FDA cleared?

No. It held Breakthrough Device designation but never obtained marketing authorisation, and the founder cited the cost of that pathway as the reason for closing the consumer app.

Unmind: Does it offer psychiatry?

No, prescribing care is not the core offer. Therapy, coaching and helpline support are, with escalation into local health systems for medication management.

Woebot Health: Is it generative AI?

Historically no. The dialogue is clinician-written and rule-based, a deliberate safety choice that limits how naturally it converses.

Unmind: Is there a minimum headcount?

Yes in practice. Unmind targets large mid-market and enterprise employers, and small organisations are not the commercial focus.

Woebot Health: What does the evidence show?

Randomised studies reported reduced depressive symptoms over short periods in selected populations, notably young adults. That is symptom change in a trial, not demonstrated population outcomes.

Share

Related pages

More on Unmind

More on Woebot Health

Keep looking

Other head to heads